Literature DB >> 34272704

Variability in Human In Vitro Enzyme Kinetics.

Christopher R Gibson1, Ying-Hong Wang2, Ninad Varkhede3, Bennett Ma3.   

Abstract

There are many factors which are known to cause variability in human in vitro enzyme kinetic data. Factors such as the source of enzyme and how it was prepared, the genetics and background of the donor, how the in vitro studies are designed, and how the data are analyzed contribute to variability in the resulting kinetic parameters. It is important to consider not only the factors which cause variability within an experiment, such as selection of a probe substrate, but also those that cause variability when comparing kinetic data across studies and laboratories. For example, the artificial nature of the microsomal lipid membrane and microenvironment in some recombinantly expressed enzymes, relative to those found in native tissue microsomes, has been shown to influence enzyme activity and thus can be a source of variability when comparing across the two different systems. All of these factors, and several others, are discussed in detail in the chapter below. In addition, approaches which can be used to visualize the uncertainty arising from the use of enzyme kinetic data within the context of predicting human pharmacokinetics are discussed.
© 2021. Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Cytochrome P450; Enzyme kinetics; Hepatocytes; Microsomes; Pharmacogenetics; UGT; Variability

Year:  2021        PMID: 34272704     DOI: 10.1007/978-1-0716-1554-6_16

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  142 in total

1.  Evaluation of fresh and cryopreserved hepatocytes as in vitro drug metabolism tools for the prediction of metabolic clearance.

Authors:  Dermot F McGinnity; Matthew G Soars; Richard A Urbanowicz; Robert J Riley
Journal:  Drug Metab Dispos       Date:  2004-07-30       Impact factor: 3.922

Review 2.  Low-Turnover Drug Molecules: A Current Challenge for Drug Metabolism Scientists.

Authors:  J Matthew Hutzler; Barbara J Ring; Shelby R Anderson
Journal:  Drug Metab Dispos       Date:  2015-09-11       Impact factor: 3.922

Review 3.  Methodological uncertainty in quantitative prediction of human hepatic clearance from in vitro experimental systems.

Authors:  D Hallifax; J B Houston
Journal:  Curr Drug Metab       Date:  2009-03       Impact factor: 3.731

4.  Effects of freezing, thawing, and storing human liver microsomes on cytochrome P450 activity.

Authors:  R E Pearce; C J McIntyre; A Madan; U Sanzgiri; A J Draper; P L Bullock; D C Cook; L A Burton; J Latham; C Nevins; A Parkinson
Journal:  Arch Biochem Biophys       Date:  1996-07-15       Impact factor: 4.013

5.  Characterization of human small intestinal cytochromes P-450.

Authors:  Q Y Zhang; D Dunbar; A Ostrowska; S Zeisloft; J Yang; L S Kaminsky
Journal:  Drug Metab Dispos       Date:  1999-07       Impact factor: 3.922

6.  The impact of solute carrier (SLC) drug uptake transporter loss in human and rat cryopreserved hepatocytes on clearance predictions.

Authors:  Patrik Lundquist; Johan Lööf; Anna-Karin Sohlenius-Sternbeck; Eva Floby; Jenny Johansson; Johan Bylund; Janet Hoogstraate; Lovisa Afzelius; Tommy B Andersson
Journal:  Drug Metab Dispos       Date:  2014-01-06       Impact factor: 3.922

7.  Intestinal and hepatic metabolic activity of five cytochrome P450 enzymes: impact on prediction of first-pass metabolism.

Authors:  Aleksandra Galetin; J Brian Houston
Journal:  J Pharmacol Exp Ther       Date:  2006-06-08       Impact factor: 4.030

Review 8.  Hepatocytes--the choice to investigate drug metabolism and toxicity in man: in vitro variability as a reflection of in vivo.

Authors:  María José Gómez-Lechón; José Vicente Castell; María Teresa Donato
Journal:  Chem Biol Interact       Date:  2006-11-28       Impact factor: 5.192

9.  Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians.

Authors:  T Shimada; H Yamazaki; M Mimura; Y Inui; F P Guengerich
Journal:  J Pharmacol Exp Ther       Date:  1994-07       Impact factor: 4.030

Review 10.  Human hepatocytes in primary culture: the choice to investigate drug metabolism in man.

Authors:  M J Gómez-Lechón; M T Donato; J V Castell; R Jover
Journal:  Curr Drug Metab       Date:  2004-10       Impact factor: 3.731

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.